Average Co-Inventor Count = 5.56
ph-index = 14
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Other (19 from 832,891 patents)
2. Pfizer Corporation (2 from 4,455 patents)
3. Esperion Therapeutics, Inc. (2 from 60 patents)
23 patents:
1. 7566695 - Multimeric apoprotein agonists
2. 7312190 - Pharmaceutical compositions of apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
3. 7307058 - Multimeric Apo A-I agonist compounds
4. 7273848 - Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
5. 7250407 - Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
6. 7211565 - Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
7. 7189689 - Apolipoprotein A-L agonists and their use to treat dyslipidemic disorders
8. 7157425 - Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
9. 6900177 - Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
10. 6844327 - Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
11. 6753313 - Multimeric Apoa-I agonist compounds
12. 6734169 - Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
13. 6716816 - Multimeric Apo A-I agonist compounds
14. 6630450 - Method of treating dyslipidemia
15. 6602854 - Branched multimeric Apo A-I agonist compounds